News Jan 23, 2024 14.00- 17.30 Proteomics Road Show Amsterdam UMC December 18, 2023 Read More Proteomics identifies biomarkers for chemotherapy response prediction in lung cancer December 18, 2023 Read More Personalized treatments – Phosphoproteomics research reveals new avenues for developing targeted therapies for patients with pancreatic cancer October 3, 2023 Read More Connie Jimenez highlighted in HUPOST as Human of HUPO September 11, 2023 Read More Published in Science Translational Medicine: Phosphoproteomics identifies hyperactive kinase targets and treatment combinations in colorectal cancer September 6, 2023 Read More 13 April. 2023, Thesis defense Valentina Cordo “On the road towards targeted treatments for T Cell Acute Lymphoblastic Leukemia: A phosphoproteomics journey” May 4, 2023 Read More Folliculin phosphoproteomics study highlighted in ASBMB Today March 14, 2023 Read More 19 jan. 2023, Thesis defense Carolien van Alphen “Unpacking the phosphoproteome in AML” January 29, 2023 Read More Connie gets HUPO Clinical and Proteome Sciences Award in Cancun Dec 7 2023. November 30, 2022 Read More Position open for mass spectrometrist November 24, 2022 Read More Souvenir IMSC2022 Clinical Proteomics Course September 20, 2022 Read More Phosphoproteomics contribution published in Nature revealing that truncated FGFR2 leads to hyperactivity and is a clinically actionable oncogene August 14, 2022 Read More CST Webinar Valentina June 10, 2022 Read More 20th Netherlands Proteomics Platform meeting with contributions from Sander and Andrea June 7, 2022 Read More Plenary lecture Connie at EuPA2022 in Leipzig June 1, 2022 Read More NPP spring meeting, Dutch Proteomics Road Show: Highlights from the institutes op 24 mei 2022, Utrecht May 17, 2022 Read More Our review on high-dose vitamin C as multi-targeting anti-cancer agent: highly down-loaded in 2021 March 26, 2022 Read More Phosphoproteomics identifies new therapies for T-cell acute lymphoblastic leukemia March 14, 2022 Read More « Previous 1 2 3 4 5 6 7 8 9 Next »
Proteomics identifies biomarkers for chemotherapy response prediction in lung cancer December 18, 2023 Read More
Personalized treatments – Phosphoproteomics research reveals new avenues for developing targeted therapies for patients with pancreatic cancer October 3, 2023 Read More
Published in Science Translational Medicine: Phosphoproteomics identifies hyperactive kinase targets and treatment combinations in colorectal cancer September 6, 2023 Read More
13 April. 2023, Thesis defense Valentina Cordo “On the road towards targeted treatments for T Cell Acute Lymphoblastic Leukemia: A phosphoproteomics journey” May 4, 2023 Read More
19 jan. 2023, Thesis defense Carolien van Alphen “Unpacking the phosphoproteome in AML” January 29, 2023 Read More
Connie gets HUPO Clinical and Proteome Sciences Award in Cancun Dec 7 2023. November 30, 2022 Read More
Phosphoproteomics contribution published in Nature revealing that truncated FGFR2 leads to hyperactivity and is a clinically actionable oncogene August 14, 2022 Read More
20th Netherlands Proteomics Platform meeting with contributions from Sander and Andrea June 7, 2022 Read More
NPP spring meeting, Dutch Proteomics Road Show: Highlights from the institutes op 24 mei 2022, Utrecht May 17, 2022 Read More
Our review on high-dose vitamin C as multi-targeting anti-cancer agent: highly down-loaded in 2021 March 26, 2022 Read More
Phosphoproteomics identifies new therapies for T-cell acute lymphoblastic leukemia March 14, 2022 Read More